Technical Analysis for VRNA - Verona Pharma plc

Grade Last Price % Change Price Change
A 60.26 -1.62% -0.99
VRNA closed down 1.62 percent on Friday, February 7, 2025, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up

Date Alert Name Type % Chg
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Multiple of Ten Bullish Other -1.62%
Inside Day Range Contraction -1.62%
Wide Bands Range Expansion -1.62%
Overbought Stochastic Strength -1.62%
Gapped Down Weakness -1.62%
New 52 Week Closing High Bullish -1.81%
Pocket Pivot Bullish Swing Setup -1.81%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 15 hours ago
Down 2 % about 17 hours ago
60 Minute Opening Range Breakdown about 17 hours ago
Down 1% about 19 hours ago
Possible Inside Day 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company's lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Respiratory Therapy Asthma Chronic Obstructive Pulmonary Disease Respiratory Diseases Cystic Fibrosis Phosphodiesterase Lung Disorders

Is VRNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

Indicators

Indicator Value
52 Week High 61.63
52 Week Low 11.395
Average Volume 1,173,183
200-Day Moving Average 29.82
50-Day Moving Average 47.37
20-Day Moving Average 54.58
10-Day Moving Average 57.81
Average True Range 2.63
RSI (14) 70.67
ADX 59.48
+DI 30.27
-DI 4.63
Chandelier Exit (Long, 3 ATRs) 53.73
Chandelier Exit (Short, 3 ATRs) 51.35
Upper Bollinger Bands 63.56
Lower Bollinger Band 45.59
Percent B (%b) 0.82
BandWidth 32.94
MACD Line 3.94
MACD Signal Line 3.59
MACD Histogram 0.3481
Fundamentals Value
Market Cap 4.93 Billion
Num Shares 81.8 Million
EPS -2.00
Price-to-Earnings (P/E) Ratio -30.13
Price-to-Sales 780.48
Price-to-Book 33.64
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 63.09
Resistance 3 (R3) 63.15 62.28 62.62
Resistance 2 (R2) 62.28 61.56 62.25 62.46
Resistance 1 (R1) 61.27 61.11 60.83 61.20 62.30
Pivot Point 60.39 60.39 60.18 60.36 60.39
Support 1 (S1) 59.39 59.67 58.95 59.32 58.22
Support 2 (S2) 58.51 59.23 58.48 58.06
Support 3 (S3) 57.50 58.51 57.91
Support 4 (S4) 57.43